Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation

Study type:

Study number:

Type of treatment:

Allogeneic

Diseases:

Short title:

Primary objective:

To assess EBMT risk score in paediatric allogeneic transplantation. To test a modified EBMT risk score with age classes adapted to paediatrics.

Key inclusion criteria:

all patients
-Aged <18 Yrs at HSCT
-Allogeneic HSCT in an EBMT registered center for an acquired haematological disease
-Date of transplant between 01.01.2000 and 31.12.2012

Country:

Principal investigator:

Fanette Bernard

EBMT Study coordinator:

Arnaud Dalissier